DIH Holding US (DHAI) Competitors $0.19 +0.01 (+3.60%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$0.20 +0.01 (+4.83%) As of 06:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DHAI vs. PYPD, CLGN, NMTC, NXL, RVP, NXGL, NEPH, PTHL, IRIX, and QTIShould you be buying DIH Holding US stock or one of its competitors? The main competitors of DIH Holding US include PolyPid (PYPD), CollPlant Biotechnologies (CLGN), NeuroOne Medical Technologies (NMTC), Nexalin Technology (NXL), Retractable Technologies (RVP), NEXGEL (NXGL), Nephros (NEPH), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), IRIDEX (IRIX), and QT Imaging (QTI). These companies are all part of the "medical equipment" industry. DIH Holding US vs. PolyPid CollPlant Biotechnologies NeuroOne Medical Technologies Nexalin Technology Retractable Technologies NEXGEL Nephros Pheton Holdings Ltd Class A Ordinary Shares IRIDEX QT Imaging DIH Holding US (NASDAQ:DHAI) and PolyPid (NASDAQ:PYPD) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk. Does the media favor DHAI or PYPD? In the previous week, PolyPid had 2 more articles in the media than DIH Holding US. MarketBeat recorded 4 mentions for PolyPid and 2 mentions for DIH Holding US. DIH Holding US's average media sentiment score of 1.43 beat PolyPid's score of 0.45 indicating that DIH Holding US is being referred to more favorably in the media. Company Overall Sentiment DIH Holding US Positive PolyPid Neutral Is DHAI or PYPD more profitable? PolyPid has a net margin of 0.00% compared to DIH Holding US's net margin of -13.59%. DIH Holding US's return on equity of -5.07% beat PolyPid's return on equity.Company Net Margins Return on Equity Return on Assets DIH Holding US-13.59% -5.07% -25.97% PolyPid N/A -624.10%-129.28% Does the MarketBeat Community favor DHAI or PYPD? PolyPid received 32 more outperform votes than DIH Holding US when rated by MarketBeat users. CompanyUnderperformOutperformDIH Holding USN/AN/APolyPidOutperform Votes3280.00% Underperform Votes820.00% Which has more volatility & risk, DHAI or PYPD? DIH Holding US has a beta of -0.17, suggesting that its share price is 117% less volatile than the S&P 500. Comparatively, PolyPid has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Do analysts rate DHAI or PYPD? PolyPid has a consensus target price of $11.33, indicating a potential upside of 304.76%. Given PolyPid's stronger consensus rating and higher possible upside, analysts clearly believe PolyPid is more favorable than DIH Holding US.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DIH Holding US 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00PolyPid 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Do insiders and institutionals have more ownership in DHAI or PYPD? 27.8% of DIH Holding US shares are held by institutional investors. Comparatively, 26.5% of PolyPid shares are held by institutional investors. 49.6% of DIH Holding US shares are held by insiders. Comparatively, 24.7% of PolyPid shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, DHAI or PYPD? DIH Holding US has higher revenue and earnings than PolyPid. DIH Holding US is trading at a lower price-to-earnings ratio than PolyPid, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDIH Holding US$64.47M0.14-$8.44M-$0.30-0.64PolyPidN/AN/A-$29.02M-$4.97-0.56 SummaryPolyPid beats DIH Holding US on 9 of the 17 factors compared between the two stocks. Get DIH Holding US News Delivered to You Automatically Sign up to receive the latest news and ratings for DHAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DHAI vs. The Competition Export to ExcelMetricDIH Holding USSurgical & medical instruments IndustryBusiness SectorNASDAQ ExchangeMarket Cap$9.12M$4.33B$22.15B$7.93BDividend YieldN/A39.93%2.59%4.23%P/E Ratio-0.6430.0330.7018.54Price / Sales0.1455.31171.49103.29Price / CashN/A51.0831.5134.62Price / Book-0.246.055.024.25Net Income-$8.44M$68.71M$194.53M$248.18M7 Day Performance12.03%-0.24%0.08%0.91%1 Month Performance-17.58%-2.90%1.51%2.58%1 Year Performance-88.10%21.00%10.65%4.02% DIH Holding US Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHAIDIH Holding US1.2652 of 5 stars$0.19+3.6%N/A-87.6%$9.12M$64.47M-0.64N/AShort Interest ↓Positive NewsHigh Trading VolumePYPDPolyPid2.1324 of 5 stars$2.70-1.9%$11.33+319.9%-44.0%$27.51MN/A-0.5480Upcoming EarningsShort Interest ↑Gap UpCLGNCollPlant Biotechnologies2.3916 of 5 stars$2.22-5.5%$12.50+463.1%-62.9%$25.43M$515,000.00-1.4470Short Interest ↑High Trading VolumeNMTCNeuroOne Medical Technologies0.5155 of 5 stars$0.54-5.6%N/A-46.7%$25.37M$5.75M-2.0620NXLNexalin Technology2.5379 of 5 stars$1.74+0.3%$5.00+187.4%+5.9%$23.15M$168,721.00-2.723Upcoming EarningsNews CoverageRVPRetractable TechnologiesN/A$0.71+2.6%N/A-31.9%$21.20M$33.05M-1.31240Gap UpNXGLNEXGEL1.5348 of 5 stars$2.77+8.9%N/A+22.4%$21.16M$8.69M-4.7710Short Interest ↓NEPHNephros2.5393 of 5 stars$1.89-4.1%$5.00+164.6%-19.0%$20.03M$14.16M-21.0030Upcoming EarningsShort Interest ↓Gap DownPTHLPheton Holdings Ltd Class A Ordinary SharesN/A$2.83+4.0%N/AN/A$18.63M$448,196.000.0011Positive NewsGap UpIRIXIRIDEX2.1268 of 5 stars$1.10+6.3%$2.00+82.6%-58.5%$18.38M$48.67M-1.63120QTIQT ImagingN/A$0.67-5.0%N/A-6.8%$18.04M$4.00M0.00N/AUpcoming EarningsGap Down Related Companies and Tools Related Companies PolyPid Alternatives CollPlant Biotechnologies Alternatives NeuroOne Medical Technologies Alternatives Nexalin Technology Alternatives Retractable Technologies Alternatives NEXGEL Alternatives Nephros Alternatives Pheton Holdings Ltd Class A Ordinary Shares Alternatives IRIDEX Alternatives QT Imaging Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DHAI) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIH Holding US, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DIH Holding US With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
